He helped build and lead the new

Cancer Center

 at Tulane Medical School. While in New Orleans, Dr. Kuske and colleagues pioneered "

accelerated partial breast irradiation

," (APBI) a

5-day alternative

 to conventional 6 weeks of

external beam whole breast irradiation

 in select

early-stage breast cancer

.  This is now one of the hottest topics in breast cancer, and the subject of 5 international randomized clinical trials worldwide. He is a co-principal investigator of the North American 4300 patient phase III trial through the NSABP and RTOG, approved and funded by the National Cancer Institute.

Dr. Kuske

 is passionate about teaching and sharing his knowledge with medical students, residents, practicing physicians, and (yes!) patients. His expertise in this important and often understated role for

oncologists

has been recognized by the American Association for Cancer Education (AACE), which elected him President in 2002 and named him a "Fellow of the AACE" the following year. Dr. Robert Kuske has been asked to deliver 25 lectureships per year over the last decade. He has recently been selected to run "The

International Breast Course

" in 2010, with doctors from all over the world convening to learn the latest about breast diagnosis and treatment. This course covers both

benign and malignant breast disease

, with cases televised live to the participants!

Why go to the student to have your

radiation treatments

, when you can go to the professor?!